Preferences for opt-in and opt-out enrollment and consent models in biobank research: a national survey of Veterans Administration patients

被引:31
|
作者
Kaufman, David [1 ]
Bollinger, Juli [1 ]
Dvoskin, Rachel [1 ]
Scott, Joan [2 ]
机构
[1] Johns Hopkins Univ, Berman Inst Bioeth, Genet & Publ Policy Ctr, Washington, DC USA
[2] Natl Coalit Hlth Profess Educ Genet, Lutherville Timonium, MD USA
关键词
biobank; genetics; informed consent; opt-out; recruitment; research ethics; BIOLOGICAL SAMPLES;
D O I
10.1038/gim.2012.45
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: In 2006, the Department of Veterans Affairs launched the Genomic Medicine Program with the goal of using genomic information to personalize and improve health care for veterans. A step toward this goal is the Million Veteran Program, which aims to enroll a million veterans in a longitudinal cohort study and establish a database with genomic, lifestyle, military-exposure, and health information. Before the launch of the Million Veteran Program, a survey of Department of Veterans Affairs patients was conducted to measure preferences for opt-in and opt-out models of enrollment and consent. Methods: An online survey was conducted with a random sample of 451 veterans. The survey described the proposed Million Veteran Program database and asked respondents about the acceptability of opt-in and opt-out models of enrollment. The study examined differences in responses among demographic groups and relationships between beliefs about each model and willingness to participate. Results: Most respondents were willing to participate under both opt-in (80%) and opt-out (69%) models. Nearly 80% said they would be comfortable providing access to residual clinical samples for research. At least half of respondents did not strongly favor one model over the other; of those who expressed a preference, significantly more people said they would participate in a study using opt-in methods. Stronger preferences for the opt-in approach were expressed among younger patients and Hispanic patients. Conclusion: Support for the study and willingness to participate were high for both enrollment models. The use of an opt-out model could impede recruitment of certain demographic groups, including Hispanic patients and patients under the age of 55 years.
引用
收藏
页码:787 / 794
页数:8
相关论文
共 49 条
  • [1] Australian Perspectives on Opt-In and Opt-Out Consent Systems for Deceased Organ Donation
    Hyde, Melissa K.
    Masser, Barbara M.
    Edwards, Abigail R. A.
    Ferguson, Eamonn
    PROGRESS IN TRANSPLANTATION, 2021, 31 (04) : 357 - 367
  • [2] A RANDOMIZED CONTROL TRIAL OF OPT-IN VERSUS OPT-OUT ENROLLMENT INTO A DIABETES MANAGEMENT INTERVENTION
    Aysola, Jaya
    Troxel, Andrea B.
    Asch, David A.
    Tahirovic, Emin
    Gangemi, Kelsey
    Hodlofski, Amanda T.
    Zhu, Jingsan
    Volpp, Kevin G.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2015, 30 : S89 - S89
  • [3] A Randomized Controlled Trial of Opt-In Versus Opt-Out Enrollment Into a Diabetes Behavioral Intervention
    Aysola, Jaya
    Tahirovic, Emin
    Troxel, Andrea B.
    Asch, David A.
    Gangemi, Kelsey
    Hodlofski, Amanda T.
    Zhu, Jingsan
    Volpp, Kevin
    AMERICAN JOURNAL OF HEALTH PROMOTION, 2018, 32 (03) : 745 - 752
  • [4] Comparing Opt-in Versus Opt-out Recruitment Strategies for Ophthalmology Research
    Weiss, David
    Murchison, Ann
    Hark, Lisa
    Collymore, Bianca
    Casten, Robin
    Brawer, Rickie
    Plumb, James
    Rovner, Barry
    Henderer, Jeffrey
    Haller, Julia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [5] Recruiting Older African Americans With Diabetes: A Comparison of Opt-in Versus Opt-out Enrollment Methods
    Weiss, David M.
    Casten, Robin J.
    Leiby, Benjamin E.
    Hark, Lisa A.
    Henderer, Jeffrey
    Rovner, Barry W.
    Haller, Julia A.
    Murchison, Ann P.
    DIABETES, 2012, 61 : A574 - A574
  • [6] Parent perspectives on consent for the linkage of data to evaluate vaccine safety: A randomised trial of opt-in and opt-out consent
    Berry, Jesia G.
    Ryan, Philip
    Duszynski, Katherine M.
    Braunack-Mayer, Annette J.
    Carlson, Jillian
    Xafis, Vicki
    Gold, Michael S.
    CLINICAL TRIALS, 2013, 10 (03) : 483 - 494
  • [7] Use of pre-enrollment randomization and delayed consent to maximize participation in a clinical trial of opt-in versus opt-out tobacco treatment
    Faseru, Babalola
    Mussulman, Laura M.
    Nazir, Niaman
    Ellerbeck, Edward F.
    Shergina, Elena
    Scheuermann, Taneisha S.
    Gajewski, Byron J.
    Catley, Delwyn
    Richter, Kimber P.
    SUBSTANCE ABUSE, 2022, 43 (01) : 1035 - 1042
  • [8] A Systematic Review of Opt-out Versus Opt-in Consent on Deceased Organ Donation and Transplantation (2006–2016)
    M. Usman Ahmad
    Afif Hanna
    Ahmed-Zayn Mohamed
    Alex Schlindwein
    Caitlin Pley
    Ingrid Bahner
    Rahul Mhaskar
    Gavin J. Pettigrew
    Tambi Jarmi
    World Journal of Surgery, 2019, 43 : 3161 - 3171
  • [9] Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies
    Junghans, C
    Feder, G
    Hemingway, H
    Timmis, A
    Jones, M
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7522): : 940 - 942
  • [10] Opt-In vs. Opt-Out Approach for Kidney Disease Education and Associated Research
    Shukla, Ashutosh M.
    Shell, Popy
    Fu, Devin S.
    Purvis, Zachary P.
    Orozco, Tatiana
    Chamarthi, Gajapathiraju
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 736 - 736